Topical steroid creams can raise blood sugar, though the risk depends heavily on the strength of the steroid, how much skin you’re covering, and whether you already have trouble with glucose control. For most people dabbing a mild hydrocortisone cream on a small rash, the effect is negligible. But when potent or super-potent formulations are used over larger areas, enough steroid enters the bloodstream to trigger the same kind of insulin resistance that oral or injected steroids are known for.
How Steroid Cream Reaches Your Bloodstream
The skin is not a perfect barrier. Corticosteroids applied to the surface can pass through the outer layers and eventually reach the bloodstream, a process called percutaneous absorption. Your skin actually contains transport proteins that actively move certain steroid molecules from the outer epidermis down into the dermis and from there into the blood. Research on these transporters, particularly one called P-glycoprotein, has shown that dexamethasone and prednisolone are actively shuttled through the skin, while some other steroids are not transported as efficiently.1PubMed. P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids This means the degree of systemic absorption is not just about how much cream you slather on; it also depends on which steroid molecule is in the formulation.
Several factors amplify how much gets through. Diseased or broken skin absorbs far more steroid than intact skin. Thin-skinned areas like the eyelids, groin, and armpits let more through than thick-skinned areas like the palms or soles. Covering the cream with a bandage or wrap, known as occlusion, increases absorption further. And children absorb proportionally more than adults because they have a higher ratio of skin surface area to body weight.2PubMed. Adverse effects of topical glucocorticosteroids
Why Absorbed Steroids Push Blood Sugar Up
Glucocorticoids, the class of steroids used in these creams, have a well-understood effect on metabolism once they reach the bloodstream. They make your cells less responsive to insulin, the hormone responsible for pulling sugar out of the blood and into cells. This is the same mechanism at work when someone takes prednisone tablets and sees their blood sugar spike. The steroid essentially tells the liver to release more glucose while simultaneously making muscle and fat cells worse at absorbing it. The result is higher circulating blood sugar levels.3PubMed Central. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism
The question with topical creams has always been whether enough steroid actually gets absorbed to trigger this cascade. For decades, many clinicians assumed that topical application was “local only,” with minimal systemic effects. The evidence says otherwise, at least in certain situations.
What the Clinical Evidence Shows
The clearest evidence comes from case reports and clinical studies that directly tracked blood sugar in patients using topical steroids. In one striking case, a 71-year-old man with well-controlled type 1 diabetes developed severe hyperglycemia after using a super-potent topical steroid for a psoriasis flare. His insulin requirements shot up to nearly five times his normal daily dose. This happened with short-duration use, highlighting that you don’t need to be applying a cream for months to see a metabolic effect.4PubMed Central. Acute Hyperglycemia Due to Topical Corticosteroid Administration
A study of diabetic patients using topical steroids (in this case, steroid eye drops, which are also absorbed systemically) documented a measurable rise in both fasting blood glucose and HbA1c. Fasting glucose peaked at roughly 157 mg/dL by the third week of treatment, up from a baseline of about 146 mg/dL, and HbA1c climbed from 7.6% to 8.2% by the seventh week. The proportion of patients with blood glucose readings above 160 mg/dL rose from about 31% before treatment to 42% during treatment.5PubMed Central. The Effect of Topical Steroids on Blood Glucose Profile in Diabetic Patients Those shifts may seem modest in isolation, but for someone managing diabetes, a sustained half-percentage-point jump in HbA1c represents a meaningful worsening of glucose control.
Perhaps the most detailed metabolic picture comes from a study of five psoriasis patients with large areas of affected skin (40% to 85% of body surface). They were treated with a potent topical steroid without any occlusion. All five showed rapid suppression of their own cortisol production, a sign that enough exogenous steroid had entered the bloodstream to influence the entire hormonal axis. More relevant to the blood sugar question, fasting insulin levels increased two- to threefold across the board, indicating significant insulin resistance. Two of the five patients also showed reduced glucose tolerance.6JAMA Network. Systemic Absorption of Topical Steroids: Metabolic Effects as an Index of Mild Hypercortisolism These findings suggest that with enough skin involvement, a potent topical steroid can produce a state resembling mild Cushing syndrome, the condition caused by chronic steroid excess.
Factors That Increase the Risk
Not every tube of steroid cream carries the same risk. Several variables determine whether your blood sugar is likely to be affected.
Steroid Potency
Topical steroids are classified from mild (class VII, like over-the-counter hydrocortisone) to super potent (class I, like clobetasol propionate). The higher the potency, the greater the systemic effect per unit area. The case report of five-times-normal insulin requirements involved a super-potent steroid, not a mild one.4PubMed Central. Acute Hyperglycemia Due to Topical Corticosteroid Administration Mild steroids applied to small patches carry far less risk. When clinicians list the systemic side effects of topical steroids, including hyperglycemia, adrenal suppression, and even Cushing syndrome, the concern is greatest with high-potency and super-potent preparations.7PubMed Central. Topical Corticosteroid-Induced Adrenal Insufficiency: A Case Report – Section: Discussion
Surface Area Covered
The more skin you treat, the more steroid reaches the bloodstream. This is why conditions like widespread psoriasis or generalized eczema carry more metabolic risk during topical steroid treatment than a small localized patch. The psoriasis patients who showed insulin resistance and cortisol suppression had between 40% and 85% of their body surface area involved.6JAMA Network. Systemic Absorption of Topical Steroids: Metabolic Effects as an Index of Mild Hypercortisolism A thumbnail-sized patch of eczema treated with a moderate-potency cream is a fundamentally different situation from full-body application.
Formulation Type
The vehicle the steroid is mixed into matters more than many people realize. Research on skin permeation shows that the percutaneous absorption of topical corticosteroids is highly dependent on the formulation itself, and less dependent on the concentration of steroid within it.8PubMed. Cutaneous Bioavailability of Corticosteroids from Topical Formulations: a Retrospective Analysis of Data from In Vitro Permeation Testing (IVPT) and In Vivo Assessments Ointments, which are greasier and more occlusive, tend to deliver more steroid into the bloodstream than creams or lotions. In one comparison, an ointment formulation produced roughly twice the systemic exposure of a lipophilic cream containing the same active ingredient.9PubMed Central. Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream If your doctor gives you a choice between an ointment and a cream, the cream generally carries a somewhat lower risk of systemic absorption, though it may also be slightly less effective for the skin condition being treated.
Children’s Vulnerability
Kids absorb more steroid per kilogram of body weight than adults do. Their skin is thinner and more permeable, and their smaller bodies mean any steroid that does get absorbed has a proportionally larger metabolic impact. Children are more susceptible to systemic adverse effects of topical corticosteroids because of this enhanced percutaneous absorption.10PubMed Central. Systemic side-effects of topical corticosteroids Pediatric dermatologists tend to prescribe the lowest potency that will do the job and limit the duration of treatment for exactly this reason.
Why People with Diabetes Should Pay Extra Attention
If you already have diabetes, you’re starting from a baseline where your glucose management is more fragile. A steroid-induced bump in insulin resistance that a non-diabetic person’s pancreas could compensate for might tip you into poorly controlled territory. The study of diabetic patients using topical steroids showed a statistically significant rise in HbA1c, from 7.6% to 8.2% over seven weeks, a swing that could move someone from “reasonably controlled” to “needs medication adjustment.”5PubMed Central. The Effect of Topical Steroids on Blood Glucose Profile in Diabetic Patients
Case reports have also described situations where switching from oral to topical steroid therapy did not eliminate the blood sugar problem as expected. In one published case, a patient’s glucose tolerance actually worsened after switching from oral to topical corticosteroids for plaque psoriasis, likely because the large area of application allowed significant systemic absorption. The authors recommend intense monitoring of blood glucose during initiation of topical steroid treatment to catch these problems early.11PubMed Central. Change of Oral to Topical Corticosteroid Therapy Exacerbated Glucose Tolerance in a Patient with Plaque Psoriasis
If you have diabetes and your doctor prescribes a topical steroid, especially a moderate-to-potent one for a large area, ask whether you should check your blood sugar more frequently during treatment. You may not need a full overhaul of your diabetes plan, but catching a rising trend early gives you and your doctor time to adjust insulin or oral medications before your HbA1c drifts significantly.
Skin-Lightening Products and Hidden Steroids
One underappreciated route of exposure is through cosmetic skin-lightening (also called skin-bleaching or depigmentation) products. In many parts of the world, particularly across West Africa and parts of Asia, products marketed for skin lightening contain potent corticosteroids, sometimes without clear labeling. These products are often used daily over large areas of the body for months or years, creating a chronic steroid exposure that dwarfs what most people get from a prescribed cream for a localized rash.
A study in Cameroon found that the prevalence of hyperglycemia among women using whitening products was about 43%. Users of these products had roughly a six-fold higher risk of hyperglycemia compared to non-users, and the risk was specifically associated with products containing corticosteroids as the active ingredient. Longer use, beyond one year, further increased the risk.12Our Dermatology Online. Factors determining the occurrence of hyperglycemia in women practicing voluntary depigmentation in four hospitals in Yaoundé, Cameroon This is an extreme example, but it illustrates how powerful the systemic effects of topical steroids can be when the dose is high and the duration is long. If you use any skin-lightening product, it’s worth checking the ingredient list for corticosteroids, and being especially cautious with products that don’t clearly list their ingredients.
When the Risk Is Low
The evidence paints a clear picture of where the risk lives, but it’s equally important to recognize when the risk is minimal. If you’re using a mild (class VI or VII) steroid like 1% hydrocortisone on a small patch of skin for a week or two, the amount of steroid that enters your bloodstream is tiny. Even people with diabetes are unlikely to notice meaningful blood sugar changes from a brief course of mild topical steroid on a limited area. The clinical cases and studies where significant hyperglycemia occurred all share common features: high-potency steroids, large areas of application, extended duration, or some combination of all three.
The scenario where you should be vigilant looks more like this: a potent or super-potent cream prescribed for a widespread skin condition, used over weeks or months, particularly if you already have diabetes or prediabetes. In these situations, your doctor should be aware of the metabolic risk, and blood sugar monitoring is a reasonable precaution.
What About Steroid Injections and Oral Steroids by Comparison
People sometimes wonder how the blood sugar effect of topical steroids compares to other routes. Oral steroids like prednisone are well known for causing hyperglycemia; this is one of the most commonly discussed side effects and a frequent headache for people with diabetes who need a steroid burst for asthma or an autoimmune flare. Injected steroids, such as cortisone shots into a joint, can also spike blood sugar for several days.
Topical steroids generally deliver less total steroid to the bloodstream than oral or injected routes, which is why the blood sugar effect is less predictable and often overlooked. But the gap between topical and systemic narrows when potent steroids are applied over large areas of compromised skin. The psoriasis patients who developed insulin resistance and cortisol suppression from topical desoximetasone alone showed metabolic effects that resembled what you would expect from a low dose of oral prednisone.6JAMA Network. Systemic Absorption of Topical Steroids: Metabolic Effects as an Index of Mild Hypercortisolism The lesson is that “topical” does not automatically mean “safe from systemic effects.” It means the systemic dose is usually lower, but not always low enough to ignore.
Steroid-Sparing Approaches in Dermatology
Dermatologists increasingly use steroid-sparing strategies for patients who need long-term treatment for conditions like eczema or psoriasis. Non-steroidal topical treatments, including calcineurin inhibitors like tacrolimus and pimecrolimus, can manage inflammation without the metabolic side effects of corticosteroids. These alternatives don’t cause hyperglycemia because they act on the immune system through a completely different pathway that doesn’t interfere with insulin signaling or glucose metabolism.
For psoriasis specifically, topical vitamin D analogs like calcipotriol are another option. Biologic medications, used for moderate-to-severe cases, target specific immune molecules and avoid the broad metabolic disruption of steroids. If you have diabetes and a chronic skin condition that has been managed with repeated courses of potent topical steroids, asking your dermatologist about these alternatives is a conversation worth having. The goal is to find a treatment plan that controls the skin disease without quietly undermining your blood sugar control in the background.
Phototherapy is another steroid-free option for conditions like psoriasis and eczema. It uses controlled ultraviolet light exposure to reduce skin inflammation and can be effective enough to reduce or eliminate the need for topical steroids in many patients. None of these alternatives are perfect: calcineurin inhibitors carry their own safety considerations, and phototherapy requires regular clinic visits. But for patients in whom steroid creams are causing metabolic problems, the alternatives are real and available.